MIRRORSTANDARD
MIRRORSTANDARD
The Unprecedented Influence of Julio Herrera Velutini on Latin American and European Finance

business Sept. 20, 2025

The Unprecedented Influence of Julio Herrera Velutini on Latin American and European Finance

Cooper Flagg: The Most Compelling NBA Prospect Since LeBron?

sports Sept. 3, 2025

Cooper Flagg: The Most Compelling NBA Prospect Since LeBron?

Trade War Escalates: Now Is the Time to Embrace a Power Struggle with Washington

politics Sept. 3, 2025

Trade War Escalates: Now Is the Time to Embrace a Power Struggle with Washington

Study Reveals Addictive Use—Not Screen Time Alone—Is the Real Threat to Youth Mental Health

health Sept. 3, 2025

Study Reveals Addictive Use—Not Screen Time Alone—Is the Real Threat to Youth Mental Health

Uber and Waymo Launch Robotaxi Service for Passengers in Atlanta

technology Sept. 3, 2025

Uber and Waymo Launch Robotaxi Service for Passengers in Atlanta

Mailed Self-Sample Kits Significantly Boost Cervical Cancer Screening Rates, Study Finds

science Sept. 3, 2025

Mailed Self-Sample Kits Significantly Boost Cervical Cancer Screening Rates, Study Finds

China Expands Influence at U.N. Cultural Agency as U.S. Withdraws Under Trump

education Sept. 3, 2025

China Expands Influence at U.N. Cultural Agency as U.S. Withdraws Under Trump

Venus Williams: 25 Things You Don’t Know About Me.

entertainment Sept. 3, 2025

Venus Williams: 25 Things You Don’t Know About Me.

science Sept. 3, 2025

Genetically Modified Bacteria Convert Plastic Waste Into Valuable Pain Relievers

Scientists have engineered bacteria that can break down plastic waste and convert it into salicylic acid, the key ingredient in aspirin, offering a promising solution to both pollution and pharmaceutical production.

Genetically Modified Bacteria Convert Plastic Waste Into Valuable Pain Relievers
Victor V. Haley

By Victor V. Haley

Published Sept. 3, 2025

In a remarkable breakthrough blending biotechnology, environmental science, and pharmaceutical innovation, researchers have successfully engineered genetically modified bacteria capable of breaking down plastic waste and converting it into salicylic acid, the active ingredient in aspirin. Focusing on PET plastics commonly found in bottles and packaging, the team used enzymes to depolymerize the plastic into terephthalic acid, which was then metabolized by genetically modified E. coli through a multi-step pathway to produce salicylic acid.

The result was a pharmaceutical-grade product matching industry standards, offering a sustainable alternative to traditional, petrochemical-heavy production. This innovation not only addresses the plastic pollution crisis but also creates a low-carbon path to medicine manufacturing. Experts have lauded the development as a key step in circular economy practices, turning waste into value while reducing industrial emissions.

The technique, still in the lab phase, is being optimized for yield and scalability, with plans for pilot programs and mobile bioconversion units in high-waste or low-resource areas. The approach could revolutionize how we deal with both environmental waste and pharmaceutical supply, with future applications potentially expanding into producing other medicines, biofuels, or chemicals. Regulatory agencies have shown interest, and early public response has been positive, though researchers acknowledge the need for thorough biosafety and ethical evaluations.

As plastic production surpasses 400 million tons annually and climate pressures demand greener industrial processes, this breakthrough exemplifies how synthetic biology can transform global sustainability efforts by converting pollution into life-saving solutions..